DR REDDYS LABORATORIES LTD

Global pharma firm providing affordable generics, APIs, and medicines to patients worldwide.

RDY | US

Overview

Corporate Details

ISIN(s):: US2561352038
LEI:
Country:: United States of America
Address:: 8-2-337, ROAD NO.3 BANJARA HILLS, HYDERABAD
Website:: https://www.drreddys.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Dr. Reddy's Laboratories Ltd., established in 1984, is an integrated global pharmaceutical company. The firm develops, manufactures, and markets a wide range of pharmaceutical products. Its core business segments include Global Generics, Pharmaceutical Services, and Active Ingredients (PSAI). The company's portfolio comprises over 190 medications, 60 active pharmaceutical ingredients (APIs), diagnostic kits, and products in critical care and biotechnology. Dr. Reddy's focuses on key therapeutic areas such as gastrointestinal, cardiovascular, pain management, oncology, neurology, and anti-infectives. Driven by the purpose "Good Health Can't Wait," the company aims to provide affordable and innovative medicines to patients worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all DR REDDYS LABORATORIES LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DR REDDYS LABORATORIES LTD

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for DR REDDYS LABORATORIES LTD via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Nanobiotix Develops a first-in-class radioenhancer to amplify radiotherapy's effect directly within tumors.	France	NANO
Nanobiotix S.A. Developing a nanotherapeutic radioenhancer that amplifies radiation to destroy solid tumors.	United States of America	NBTX
Nanoform Finland OYJ Pharma tech firm engineering nanoparticles to enhance drug performance and development.	Finland	NANOFH
NanoGroup S.A. Develops patented nanotechnology for oncology and transplantology diagnostics and therapies.	Poland	NNG
NanoRepro AG Develops and distributes rapid diagnostic self-tests for early disease detection.	Germany	NN6
NANOVIRICIDES, INC. Developing biomimetic nanomachines as broad-spectrum drugs to neutralize viral infections.	United States of America	NNVC
Nasus Pharma Ltd Develops powder-based intranasal drugs for rapid delivery in acute medical emergencies.	United States of America	NSRX
NATAC Develops sustainable plant extracts for nutraceutical, pharma, food, and animal nutrition industries.	Spain	NAT
Natera, Inc. Provides non-invasive cfDNA tests for oncology, women's health, and organ health.	United States of America	NTRA
Naturalendo Tech Co., Ltd Biotech R&D of natural ingredients for health and wellness solutions.	South Korea	168330